Treatment information
Some of the principal treatments carried out by
Dr Amit Bahl at Spire include:
Other treatments
- Chemotherapy
- Radiotherapy
Back to top
Professional profile
I am a Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre with a special interest in breast and urological cancers.
I have led and developed the prostate brachytherapy service at Bristol and been an expert adviser to NICE for the technology appraisal of new drugs and an external service reviewer.
I am a current member of the National Cancer Research Institute for prostate and bladder cancer, and have supervised several research projects. I am actively involved in research into breast, prostate and bladder cancers and participate in clinical trials. I regularly publish articles and present at many national and international meetings.
I have previously been in the NCRI Renal clinical studies group and I am an Executive Committee member of the British Uro-oncology group. I have been awarded the fellowship of the Royal College of Physicians. and in 2012 was awarded the Cochrane Shanks Jalil Professorship by the Royal College of Radiologists, London.
Clinical Interests
Radiotherapy
Chemotherapy
Bladder cancer
Breast cancer
Genito-urinary cancer
Kidney cancer
Prostate cancer
Current NHS posts
Consultant Clinical Oncologist, Bristol Cancer Institute, University Hospitals Bristol NHS Trust
Back to top
Financial Interests
Dr Bahl is a national cancer consultant adviser for Spire for a payment of £12,000 per annum. Duties include advising the Spire Group Medical Director on various matters relating to cancer, including clinical governance and national cancer standards. He is also an Oncology adviser at Spire Oncology Centre, South West for a payment of £12,000 per annum. Duties include advisory services on clinical governance, treatment protocols, quality assurance and technology and information systems in relation to the centre.
Back to top
